{"id":"W2976926951","doi":"10.1016/j.afos.2019.09.003","title":"Osteoporosis liaison service in Japan","year":2019,"lang":"en","type":"review","venue":"Osteoporosis and Sarcopenia","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eli Lilly Japan; Pfizer Japan; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Astellas Foundation for Research on Metabolic Disorders; Taisho Toyama Pharmaceutical Company; Astellas Pharma; Mochida Pharmaceutical Company; Asahi Kasei Pharma Corporation; Ono Pharmaceutical; Eisai; Teijin Pharma; Daiichi-Sankyo; Eisai Canada; Takeda Pharmaceutical Company","keywords":"Medicine; Osteoporosis; Fragility fracture; Service (business); Secondary prevention; Fracture (geology); Fragility; Primary prevention; Physical therapy; Internal medicine; Bone mineral; Engineering; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008890594,0.0007059412,0.001092951,0.003061779,0.0006148088,0.001145507,0.0007371521,0.0011859,0.007704078],"category_scores_gemma":[0.001149387,0.0003040406,0.0006502548,0.0039185,0.0003565766,0.001009457,0.00084972,0.001171623,0.001306223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001306107,"about_ca_system_score_gemma":0.004897147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01002224,"about_ca_topic_score_gemma":0.0208264,"domain_scores_codex":[0.99955,0.00008406938,0.0001165396,0.0000750776,0.0001239098,0.00005028282],"domain_scores_gemma":[0.999293,0.0001887725,0.0001546636,0.00001208339,0.0002387753,0.0001128415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001270729,0.0001117982,0.0009390489,0.04807414,0.000163843,0.0002726429,0.0001766517,0.00008181268,0.0005226226,0.001500172,0.06860477,0.8794255],"study_design_scores_gemma":[0.0001012519,0.0001392613,0.01029977,0.01742491,0.0005401358,0.001586363,0.0002425076,0.00005476265,0.0002245729,0.0004798744,0.9688745,0.00003212653],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00020402,0.9974692,0.00002418922,0.000395252,0.0002882429,0.000008683124,0.00003620433,0.000007026887,0.001567241],"genre_scores_gemma":[0.002199822,0.9961799,0.0001302109,0.0004283613,0.0001908725,0.00001826242,0.0000855566,0.000001832042,0.0007650609],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01002224,"threshold_uncertainty_score":0.02577269,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07736174565727015,"score_gpt":0.3772257575387832,"score_spread":0.2998640118815131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}